REPR - Repro Med Systems, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/20172/28/20172/29/2016
Total Revenue17,353.73715,976.67312,293.65512,247.338
Cost of Revenue6,543.2496,209.9354,724.0974,644.435
Gross Profit10,810.4889,766.7387,569.5587,602.903
Operating Expenses
Research Development241.12460.704237.486207.282
Selling General and Administrative8,495.5657,913.4847,767.7125,942.671
Non Recurring----
Others----
Total Operating Expenses15,589.20114,492.83213,029.90611,065.954
Operating Income or Loss1,764.5361,483.841-736.2511,181.384
Income from Continuing Operations
Total Other Income/Expenses Net-587.58685.183-40.448-38.814
Earnings Before Interest and Taxes1,764.5361,483.841-736.2511,181.384
Interest Expense---1.886-3.412
Income Before Tax1,176.951,569.024-776.6991,142.57
Income Tax Expense266.38483.076-241.7359.706
Minority Interest----
Net Income From Continuing Ops910.571,085.948-534.999782.864
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income910.571,085.948-534.999782.864
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares910.571,085.948-534.999782.864